Tobacco Policy/Regulatory Factors

Title Bladder Cancer Treatment Breast Cancer Treatment Colorectal Cancer Treatment Melanoma of the Skin Treatment
Year Range 1995-2019 1987-2020 1987-2020 2001-2018
Measure

Percentage of patients with non-muscle invasive bladder cancer receiving intravesical therapy.

Percentage of women aged 20 and older, diagnosed with node-positive, stage I–IIIA breast cancer, receiving multi-agent chemotherapy.

Percent of individuals, aged 20 years and older, diagnosed with stage III colon cancer or stage II-III rectal cancer who are receiving adjuvant chemotherapy.

Percentage of individuals with advanced (stage III or IV) melanoma of the skin receiving chemotherapy.
Recent Summary Trend Non-Significant Change Non-Significant Change Stable Rising
Recent Summary Trend Year Range 2009-2019 2015-2020 2015-2020 2011-2018
Desired Direction Rising Rising Rising Rising
Summary Graph

Summary graph for Bladder Cancer Treatment- Click to see detailed view of graph

Summary graph for Breast Cancer Treatment- Click to see detailed view of graph

Summary graph for Colorectal Cancer Treatment- Click to see detailed view of graph

Summary graph for Melanoma of the Skin Treatment- Click to see detailed view of graph
Trends and Most Recent Estimates In 2019, 35.5% of patients with non-muscle invasive disease received intravesical therapy. In 2020, 56.7% of women diagnosed with node positive breast cancer, received multi-agent chemotherapy. In 2020, 56.8% of stage III colon and stage II and III rectal patients received chemotherapy as part of their treatment strategy. In 2018, 79.4% of stage III or IV melanoma of the skin patients aged 20 years and older received chemotherapy.
Healthy People 2030 Target No Healthy People Target for this measure. No Healthy People Target for this measure. No Healthy People Target for this measure. No Healthy People Target for this measure.
More Information Bladder Cancer Treatment Breast Cancer Treatment Colorectal Cancer Treatment Melanoma of the Skin Treatment